<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Infectious Disease Epidemiology</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/046201DF-773B-4DBE-99E4-089E1DF6C554"><gtr:id>046201DF-773B-4DBE-99E4-089E1DF6C554</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Ferguson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0001306"><gtr:id>9581790A-6839-4A5C-803B-F1D211278488</gtr:id><gtr:title>Epidemiology and control of viral pathogens evolving under immune and drug imposed selection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0001306</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-10-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-10-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>312464</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Univ of Pittsburgh (Don Burke) via NIH MIDAS network</gtr:description><gtr:id>8256C8FB-549D-4EFE-9112-CADF71B67FC1</gtr:id><gtr:impact>This work represented a major source of evidence to support pandemic preparedness work undertaken by the US, UK, WHO and other countries. Outputs were PubMed ID 16642006 and the following 2005 paper: Ferguson NM; Cummings DA; Cauchemez S; Fraser C; Riley S; Meeyai A; Iamsirithaworn S; Burke DS. (08 Sep 2005). Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 437:209-214. (PubMed ID 16079797)</gtr:impact><gtr:outcomeId>07E39C57296-1</gtr:outcomeId><gtr:partnerContribution>Collection of data, exchange of ideas, interaction with US policymakers</gtr:partnerContribution><gtr:piContribution>I developed pandemic influenza simulations for modelling intervention strategies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>2020 Vision lecture to school children</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8AD1FE9E-EB4A-4381-B516-9F338154F034</gtr:id><gtr:impact>Lecture to 500 school children at a 1 day '2020 vision' science meeting for children in London

Awareness of science behind pandemic planning</gtr:impact><gtr:outcomeId>383490BC17D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heron-Allen Lecture at Lady Margaret Hall Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1698F4F2-E2DA-4F07-ADAE-F769627DD261</gtr:id><gtr:impact>Public lecture

Increased awareness</gtr:impact><gtr:outcomeId>D158E4AD231</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Attendance at World Economic Forum, Davos</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E6556888-8666-49E9-A6F9-5F8A0912412E</gtr:id><gtr:impact>Attended WEF meeting to talk about pandemics, emergin infections, modelling

Increased awareness</gtr:impact><gtr:outcomeId>B7D9F9DECD9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>525000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Microsoft Grant: To develop a global epidemic simulator</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Microsoft Research</gtr:fundingOrg><gtr:fundingRef>2007-068</gtr:fundingRef><gtr:id>127A08B8-6501-428E-BE7C-105A635F1FE7</gtr:id><gtr:outcomeId>3F933747CFC0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>364242</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH MIDAS Initiative: Mathematical Models in the study of Infectious Disease spread and control (2006-10)</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>7U01GM070708-03/111934-3</gtr:fundingRef><gtr:id>DE823BB4-D784-4442-A4E5-17C995575D94</gtr:id><gtr:outcomeId>D63705692CF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Translational Centres 2006</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>98AA4FEA-CB6A-4834-85C4-CBF70C870CDB</gtr:id><gtr:outcomeId>F8EB85576B40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DH Pandemic Influenza Scientific Advisory Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>285CCD8C-BF31-438E-BEDD-6899B1F2AA87</gtr:id><gtr:outcomeId>CF225C8D928</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DH Flu colloquium led by SofS DH</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>872A6A32-3547-4C21-A162-DFC6B5832137</gtr:id><gtr:outcomeId>1312F4ACA05</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Numerous citations in UK DH, US DHHS and WHO planning documents</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4EE05B85-DE5D-4494-AC38-3407F3340550</gtr:id><gtr:outcomeId>F09C17F1942</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://europepmc.org/abstract/MED/16642006</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C02782FA-8076-4945-87FE-3F0651B45AD9</gtr:id><gtr:title>Incorporating demographic stochasticity into multi-strain epidemic models: application to influenza A.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e61bea3526f76ccaabc19e2221485b1a"><gtr:id>e61bea3526f76ccaabc19e2221485b1a</gtr:id><gtr:otherNames>Minayev P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>CE5B49086EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44CC71F5-42A3-4A19-849A-FEDE90E5F9DC</gtr:id><gtr:title>Improving the realism of deterministic multi-strain models: implications for modelling influenza A.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e61bea3526f76ccaabc19e2221485b1a"><gtr:id>e61bea3526f76ccaabc19e2221485b1a</gtr:id><gtr:otherNames>Minayev P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>6CC3671572C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FEC57F1-41E8-4A5C-AFA9-665DDD1BAD2B</gtr:id><gtr:title>Interactions of multiple strain pathogen diseases in the presence of coinfection, cross immunity, and arbitrary strain diversity.</gtr:title><gtr:parentPublicationTitle>Physical review letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729efb596d9b51769b10446238b2b3a3"><gtr:id>729efb596d9b51769b10446238b2b3a3</gtr:id><gtr:otherNames>Abu-Raddad LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0031-9007</gtr:issn><gtr:outcomeId>8589BF69891</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0001306</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>